<Record>
<Term>M A Radiolabeled Anti-Carcinoma</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Radioimmunoconjugate</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Radiopharmaceutical Compound/Radioimmunoconjugate/M A Radiolabeled Anti-Carcinoma</ClassificationPath>
<BroaderTerm>Radioimmunoconjugate</BroaderTerm>
<BroaderTerm>Radiopharmaceutical Compound</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>M A Radiolabeled Anti-Carcinoma</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>M A Radiolabeled Anti-Carcinoma</Synonym>
<Description>A radiolabeled monoclonal antibody (also known as B72.3) directed against the tumor-associated glycoprotein (TAG)-72 with potential use in cancer radioimmunodiagnostics, radioimmunoscintigraphy, and radioimmunoguided surgery (RIGS). (TAG)-72 is an antigen that may be expressed by breast, colorectal, and ovarian carcinomas. (NCI04)</Description>
<Source>NCI Thesaurus</Source>
</Record>
